DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
CR-3465
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cysteinyl leukotriene receptor 1 antagonist
CR-3465
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHA-543613
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
PHA-543613
×
Maximum Phase:
1
First Approval:
None
UNII:
R36R9KVD6Y
Molecule Type:
Small molecule
Molecular Formula:
C15H17N3O2
Molecular Weight:
271.32
AlogP:
1.65
PSA:
58.37
HBD:
1.0
HBA:
#RotB:
2.0
Source:
NORBUPRENORPHINE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
NORBUPRENORPHINE
×
Maximum Phase:
1
First Approval:
None
UNII:
7E53B4O073
Molecule Type:
Small molecule
Molecular Formula:
C25H35NO4
Molecular Weight:
413.56
AlogP:
3.29
PSA:
70.95
HBD:
3.0
HBA:
#RotB:
2.0
Source:
LODAPOLIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Melanoma; Neoplasms; Pancreatic Neoplasms
Unknown
LODAPOLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
NR4MAD6PPB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
D-3263
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Transient receptor potential cation channel subfamily M member 8 agonist
D-3263
×
Maximum Phase:
1
First Approval:
None
UNII:
70FBL3TX3E
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACHN-975
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ACHN-975
×
Maximum Phase:
1
First Approval:
None
UNII:
48CET2EN53
Molecule Type:
Small molecule
Molecular Formula:
C20H23N3O4
Molecular Weight:
369.42
AlogP:
0.01
PSA:
124.68
HBD:
5.0
HBA:
#RotB:
5.0
Source:
LGD-6972
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
LGD-6972
×
Maximum Phase:
1
First Approval:
None
UNII:
6IJ842I0Z2
Molecule Type:
Small molecule
Molecular Formula:
C43H46N2O5S
Molecular Weight:
702.92
AlogP:
8.83
PSA:
112.57
HBD:
3.0
HBA:
#RotB:
11.0
Source:
BORNEOL
1
Small molecule
Investigational
Unknown
Unknown
Angina, Stable
Unknown
BORNEOL
×
Maximum Phase:
1
First Approval:
None
UNII:
M89NIB437X
Molecule Type:
Small molecule
Molecular Formula:
C10H18O
Molecular Weight:
154.25
AlogP:
2.19
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
IRGD
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Pancreatic Ductal
Unknown
IRGD
×
Maximum Phase:
1
First Approval:
None
UNII:
Z8MXU5GH4Q
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CEP-9722
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Mantle-Cell; Neoplasms
Unknown
CEP-9722
×
Maximum Phase:
1
First Approval:
None
UNII:
B68083E4YG
Molecule Type:
Small molecule
Molecular Formula:
C24H26N4O3
Molecular Weight:
418.5
AlogP:
2.62
PSA:
68.88
HBD:
1.0
HBA:
#RotB:
3.0
Source:
SULTHIAME
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy
Carbonic anhydrase inhibitor
SULTHIAME
×
Maximum Phase:
1
First Approval:
None
UNII:
I00Q766CZ2
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O4S2
Molecular Weight:
290.37
AlogP:
0.26
PSA:
97.54
HBD:
1.0
HBA:
#RotB:
2.0
Source:
LOSATUXIZUMAB VEDOTIN
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
LOSATUXIZUMAB VEDOTIN
×
Maximum Phase:
1
First Approval:
None
UNII:
17C83BVV62
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PLAMOTAMAB
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell
Unknown
PLAMOTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
5ENX424FNF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALOFANIB
1
Small molecule
Investigational
Unknown
Unknown
Stomach Neoplasms
Unknown
ALOFANIB
×
Maximum Phase:
1
First Approval:
None
UNII:
LQX7RFK8MZ
Molecule Type:
Small molecule
Molecular Formula:
C19H15N3O6S
Molecular Weight:
413.41
AlogP:
3.46
PSA:
139.5
HBD:
2.0
HBA:
#RotB:
6.0
Source:
SYM-022
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SYM-022
×
Maximum Phase:
1
First Approval:
None
UNII:
7TQ52FVC2L
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-1614235
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
GSK-1614235
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TALINOLOL
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Obesity, Morbid
Unknown
TALINOLOL
×
Maximum Phase:
1
First Approval:
None
UNII:
3S82268BKG
Molecule Type:
Small molecule
Molecular Formula:
C20H33N3O3
Molecular Weight:
363.5
AlogP:
3.27
PSA:
82.62
HBD:
4.0
HBA:
#RotB:
7.0
Source:
ELTANEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELTANEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
Q59IQJ9NTK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F6N6O
Molecular Weight:
428.3
AlogP:
3.26
PSA:
99.58
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FALNIDAMOL
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Epidermal growth factor receptor erbB1 inhibitor
FALNIDAMOL
×
Maximum Phase:
1
First Approval:
None
UNII:
0MU316797D
Molecule Type:
Small molecule
Molecular Formula:
C18H19ClFN7
Molecular Weight:
387.85
AlogP:
3.46
PSA:
78.86
HBD:
2.0
HBA:
#RotB:
4.0
Source:
MOSUNETUZUMAB
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular
B-lymphocyte antigen CD20 binding agent
MOSUNETUZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
LDJ89SS0YG
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MMV-390048
1
Small molecule
Investigational
Unknown
Unknown
Malaria; Malaria, Falciparum
Unknown
MMV-390048
×
Maximum Phase:
1
First Approval:
None
UNII:
0Z5T00JJ10
Molecule Type:
Small molecule
Molecular Formula:
C18H14F3N3O2S
Molecular Weight:
393.39
AlogP:
3.82
PSA:
85.94
HBD:
1.0
HBA:
#RotB:
3.0
Source:
REGN4018
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
REGN4018
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MUPLESTIM
1
Protein
Investigational
Unknown
Unknown
HIV Infections
Unknown
MUPLESTIM
×
Maximum Phase:
1
First Approval:
None
UNII:
A802907MI4
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-06671008
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
PF-06671008
×
Maximum Phase:
1
First Approval:
None
UNII:
2GWZ8HN70W
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
EFMOROCTOCOG ALFA
1
Unknown
Investigational
Unknown
Unknown
Hemophilia A
Unknown
EFMOROCTOCOG ALFA
×
Maximum Phase:
1
First Approval:
None
UNII:
7PCM518YLR
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AK-01
1
Unknown
Investigational
Unknown
Unknown
Breast Neoplasms; Neuroblastoma; Small Cell Lung Carcinoma
Unknown
AK-01
×
Maximum Phase:
1
First Approval:
None
UNII:
1WX8O5XV4R
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-2239633
1
Small molecule
Investigational
Unknown
Unknown
Asthma
Unknown
GSK-2239633
×
Maximum Phase:
1
First Approval:
None
UNII:
07ODS257BP
Molecule Type:
Small molecule
Molecular Formula:
C21H19ClN4O5S2
Molecular Weight:
506.99
AlogP:
3.54
PSA:
122.55
HBD:
3.0
HBA:
#RotB:
8.0
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
FP-1305
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
FP-1305
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
90
91
92
93
94
95
96
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA